Delivery Order SPE2DB22D2006-SPE2DB25FV7PW

Award Date 1/14/25
Potential Completion Date 2/5/25
Potential Value $35K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,634.70, is for the supply of AVEED 750 MG/3 ML VIAL 3ML, a medical product. The contract is a firm fixed-price delivery order, with a period of performance running through February 5, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $23,123.28, is for the delivery of 4567105547 AVEED 750 MG/3 ML VIAL 3ML, a specialty medication. The contract has an ultimate completion date of February 18, 2025 and is a Firm Fixed Price Delivery Order. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of AVEED 750 MG/3 ML VIAL 3ML medical products. The $9,634.70 firm fixed-price delivery order has a completion date of February 20, 2025 and is not designated under any set-aside program. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical, a significant customer of the company. The $18,636.48 contract is for the supply of AVEED 750 MG/3 ML VIAL 3ML, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables the DLA to efficiently procure a comprehensive range of medical commodities from...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $27,954.72, is for the delivery of the drug AVEED 750 MG/3 ML VIAL 3ML. This award is placed under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, which has a ceiling value of up to $999,999,999.00 and runs through December 31, 2025. The IDC allows the DLA to efficiently...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,243.36, is for the delivery of AVEED 750 MG/3 ML VIAL 3ML, a specialty pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of January 26, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,926.94 and an ultimate completion date of February 13, 2025. The contract is for the provision of AVEED 750 MG/3 ML VIAL 3ML, a pharmaceutical product. This contract is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
The Defense Logistics Agency (DLA) awarded a $27,954.72 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation, to provide 4563871377 AVEED 750 MG/3 ML VIAL 3ML pharmaceutical products. This delivery order is part of an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through December 31, 2025, which serves as the primary contract vehicle for Amerisourcebergen to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of AVEED 750 MG/3 ML vials, a specialty pharmaceutical product. The award has a ceiling value of $7,765.20 and a period of performance through November 26, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,329.56 firm-fixed-price delivery order is for the supply of AVEED 750 MG/3 ML VIAL 3ML, a specialty medication. The contract has an ultimate completion date of August 20, 2024 and was awarded on July 30, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up...
  • SPE2DB22D2006
    Indefinite Delivery Contract
  • SPE2DB22D2006-SPE2DB25FV7PW
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $34,684.92, is for the delivery of 4566936597 - AVEED 750 MG/3 ML VIAL 3ML, a medical product. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has a firm fixed price pricing type and an ultimate completion date of February 5, 2025. It does not have a set-aside designation, indicating open competition.

Generated 4/21/25, 3:44 AM